Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets.

Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets.

Item
http://www.wikidata.org/entity/Q37866334
Rewiring of sIgM-mediated intracellular signaling through the CD180 Toll-like receptor.Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia.The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignanciesCD79B limits response of diffuse large B cell lymphoma to ibrutinib.Growth inhibition and apoptosis of neuroblastoma cells through ROS-independent MEK/ERK activation by sulforaphane.Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes.The phosphoinositide 3-kinase pathway in chronic lymphocytic leukemia: evidence for phosphatase and tensin homolog deletion on chromosome 10 deregulation.Amplification of B cell receptor-Erk signaling by Rasgrf-1 overexpression in chronic lymphocytic leukemia.
P2860

Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets.

Item
http://www.wikidata.org/entity/Q37866334
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@en
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@nl
type
label
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@en
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@nl
prefLabel
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@en
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Aberrantly activated anti-apop ...... of novel therapeutic targets.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2141.2011.08676.X
P407
P433
P478
P577
P5875
P698
P921